The Neurobiology Unit aims at developing new restorative and neuroprotective treatments for neurodegenerative diseases using cell transplantation and direct in vivo gene delivery.
The Neuronal Survival Unit is focused on pathogenetic mechanisms and pharmacological treatment in cell and animal models of Parkinson’s and Huntington’s diseases.
The Basal Ganglia Pathophysiology team explores molecular and cellular plasticity in the basal ganglia after damage and/or pharmacological treatment.
The research involves outcomes measures intended to reflect illness from the patients’ perspective, as well as clinical assessment tools. Ongoing work involves instruments tapping areas such as motor dysfunction, perceived health, distress, and functional status.
The BRAINS UNIT is focused on the development of new therapeutic strategies for neurodegenerative diseases. The research is a synthesis of mechanisms of repair in the brain and in vivo imaging at the systems level
The research involves the Acoustic Trapping Project aimed at performing particle and cell trapping in a perfusion based microfluidic system. The technique will provide a platform for performing cellassays in a non-contact way using ultrasonic standing waves.
The CNS Gene Therapy Team develop systems for sufficient and sustained expression of transgenes in the CNS. Gene transfer is used to express trophic factors or neurotransmitter-producing enzymes in animal models of neurodegenerative disease.
The Cultural Research Team looks at the cultural aspects on neurodegenerative disorders such as Parkinson’s and Huntington’s disease.
Åsa Petersén's team focuses on the neuropsychiatric Huntington’s disease, and studies molecular mechanisms in the interface to depression, dementia and obesity.
The projects aim at transferring preclinical results into a clinical experimental therapeutics programme in Parkinsons disease, and inflammatory disorders in the nervous system.
Page Manager: Jens Persson
Last modified: 2011-07-22
